Corporate Vice President, R&D Business Development, Novo Nordisk
John McDonald joined Novo Nordisk in October 2018 as Corporate Vice President, Global R&D Business Development. From June 2011 through September 2018 John was Vice President, Business Development at Biogen. From May 2006 through June 2011 John was a managing director at MPM Capital, one of the world’s largest science-dedicated venture capital firms, focusing on company formation and supporting portfolio company business development efforts. Working with Millennium Pharmaceuticals, Inc. from April 2000 through May 2006, John was Vice President of Business Development. Prior to April 2000, John worked at both Genentech, Inc. and Genzyme Corporation where he led or participated in various business development transactions.